[ReneSola Elaborates on U.S. Department of Commerce Investigation Regarding Jiashan, China, Mar. 27, 2014 -- ReneSola Ltd (“ReneSola”) (NYSE: SOL), a leading brand and technology provider of solar photovoltaic (“PV”) products, today elaborated on a pending U.S. Department of Commerce (“Department”)’s anti-dumping and countervailing duty investigation regarding certain crystalline silicon PV products from China. On December 31, 2013, a petition] []
[Cleantech Solutions International Reports Fourth Quarter and Full Year 2013 Results ● ● Wuxi, Jiangsu Province, China March 31, 2014 “We closed the year with solid financial performance. Full year revenue exceeded expectations and net income nearly doubled, despite the impact of a non-cash impairment charge related to equipment held for operating lease at year end. The primary driver of] [Cleantech Solutions International Announces Conference Call to Discuss Fourth Quarter and Full Year 2013 Financial Results WUXI, Jiangsu, China, March 27, 2014 - Cleantech Solutions International, Inc. ("Cleantech Solutions" or "the Company") (CLNT), a manufacturer of metal components and assemblies, primarily used in the wind power and other industries and dyeing and finishing equipment to the textile industry, today announced] [FORM 8-K CURRENT REPORT Date of report (Date of earliest event reported): March 27, 2014 CLEANTECH SOLUTIONS INTERNATIONAL, INC. Nevada 001-34591 90-0648920 (State or other jurisdiction of incorporation or organization) (Commission File No.) (IRS Employee Identification No.) No. 9 Yanyu Middle Road Qianzhou Village, Huishan District, Wuxi City Jiangsu Province, People’s Republic of China (86) 51083397559 Copies to: Asher S.]
[FORM 8-K CURRENT REPORT Date of report (Date of earliest event reported): March 31, 2014 (March 28, 2014) CHINA JO-JO DRUGSTORES, INC. Nevada 001-34711 98-0557852 (State or other jurisdiction of incorporation) (Commission File No.) (IRS Employer Identification No.) 1st Floor, Yuzheng Plaza No.76, Yuhuangshan Road Hangzhou, Zhejiang Province People’s Republic of China (Zip Code) +86 (571) 88077078 N/A (Former name]
[] [CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM We hereby consent to the incorporation by reference in the Registration Statements on Form S-3 (No. 333-179694 and No. 333-179260) and Form S-8 (No. 333-177661) of Kingold Jewelry, Inc. of our reports dated March 31, 2014, relating to the consolidated financial statements and the effectiveness of internal control over financial reporting, which appear] [CERTIFICATION OF CHIEF EXECUTIVE OFFICER UNDER SECTION 302 OF THE SARBANES-OXLEY ACT I, Zhihong Jia, certify that: 1. 2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not] [CERTIFICATION OF CHIEF FINANCIAL OFFICER UNDER SECTION 302 OF THE SARBANES-OXLEY ACT I, Bin Liu, certify that: 1. 2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not] [18 U.S.C. SECTION 1350, SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002 (1) (2) Zhihong Jia Chairman of the Board and Chief Executive Officer] [18 U.S.C. SECTION 1350, SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002 (1) (2) Bin Liu Chief Financial Officer]
[58.com Announces Pricing of Follow-on Public Offering of American Depositary Shares BEIJING, CHINA, March 28, 2014 -- 58.com Inc. (NYSE: WUBA) (the “Company”) today announced that the previously announced registered follow-on public offering of American depositary shares (“ADSs”) by the Company and certain selling shareholders was priced at US$38.00 per ADS. The Company will issue and sell 2,000,000 ADSs and] []
[ReneSola Elaborates on U.S. Department of Commerce Investigation Regarding Jiashan, China, Mar. 27, 2014 -- ReneSola Ltd (“ReneSola”) (NYSE: SOL), a leading brand and technology provider of solar photovoltaic (“PV”) products, today elaborated on a pending U.S. Department of Commerce (“Department”)’s anti-dumping and countervailing duty investigation regarding certain crystalline silicon PV products from China. On December 31, 2013, a petition] []
[TABLE OF CONTENTS Page PART I 3 Item 1. Business 3 Item 1A. Risk Factors 10 Item 1B. Unresolved Staff Comments 20 Item 2. Properties 20 Item 3. Legal Proceedings 22 Item 4. Mine Safety Disclosures 23 PART II 23 Item 5. 23 Item 7. Management’s Discussion and Analysis of Financial Conditions and Results of Operations] [CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM We hereby consent to the incorporation by reference in the Registration Statement on Form S-3 (No. 333-192657) and Registration Statement on Form S-8 (No. 333-181010) of our report dated March 31, 2014, relating to the consolidated financial statements of Skystar Bio-Pharmaceutical Company and its subsidiaries (collectively the “Company”), which appears in this Annual] [SECTION 302 OF THE SARBANES-OXLEY ACT OF 2002 I, Weibing Lu, certify that: 1. I have reviewed this annual report on Form 10-K of Skystar Bio-Pharmaceutical Company; 2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of] [SECTION 302 OF THE SARBANES-OXLEY ACT OF 2002 I, Bing Mei, certify that: 1. I have reviewed this annual report on Form 10-K of Skystar Bio-Pharmaceutical Company; 2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of] [18 U.S.C. SECTION 1350, SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002 (2) The information contained in the Report fairly presents, in all material respects, the financial condition and result of operations of the Company at the dates and for the periods indicated. March 31, 2014 Weibing Lu Chief Executive Officer] [18 U.S.C. SECTION 1350, SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002 (2) The information contained in the Report fairly presents, in all material respects, the financial condition and result of operations of the Company at the dates and for the periods indicated. March 31, 2014 Bing Mei Chief Financial Officer]
[FORM 8-K CURRENT REPORT Date of report (Date of earliest event reported): March 31, 2014 (March 28, 2014) CHINA JO-JO DRUGSTORES, INC. Nevada 001-34711 98-0557852 (State or other jurisdiction of incorporation) (Commission File No.) (IRS Employer Identification No.) 1st Floor, Yuzheng Plaza No.76, Yuhuangshan Road Hangzhou, Zhejiang Province People’s Republic of China (Zip Code) +86 (571) 88077078 N/A (Former name]
[58.com Announces Pricing of Follow-on Public Offering of American Depositary Shares BEIJING, CHINA, March 28, 2014 -- 58.com Inc. (NYSE: WUBA) (the “Company”) today announced that the previously announced registered follow-on public offering of American depositary shares (“ADSs”) by the Company and certain selling shareholders was priced at US$38.00 per ADS. The Company will issue and sell 2,000,000 ADSs and] []
[Montage Technology Announces Preliminary First Quarter Revenue Results Exceeding Guidance SHANGHAI, China March 31, 2014 The increased revenue expectations reflect higher sales of Montages memory interface solutions due to growing demand for LRDIMMs. As a result, memory interface revenue is expected to increase more than 60 percent sequentially. Gross margin for the first quarter 2014 is expected to be] [Montage Technology Announces Filing of Form 12b-25 Notification of Late Filing for 2013 10-K SHANGHAI, China, March 31, 2014 Form 12b-25 Notification of Late Filing for 2013 10-K. In its 12b-25 Notification of Late Filing, the Company indicated that its Form 10-K cannot be finalized until the completion of the audit committees review of allegations contained in reports issued by] [Item 7.01 Regulation FD Disclosure Item 8.01 Other Events 99.1 Press Release dated March 31, 2014 announcing revised earnings guidance.]
